Status:
COMPLETED
Prostate Cancer Screening: Fostering Informed Decisions
Lead Sponsor:
Georgetown University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Eligibility:
MALE
40-70 years
Phase:
PHASE3
Brief Summary
The primary goal of this study is to develop and evaluate a print-based method of patient education with a decision tool that is designed to provide detailed information about prostate cancer and to c...
Detailed Description
In spite of the significant disease burden presented by PCa, the utility of screening asymptomatic men remains controversial, as it has not yet been demonstrated by a randomized trial that early diagn...
Eligibility Criteria
Inclusion
- Inclusion criteria are: 1) 40-70 years old, 2) English-speaking, and 3) ability to provide meaningful consent.
Exclusion
- The exclusion criteria are: 1) a history of cancer (with the exception of basal cell carcinoma), and 2) a history of prostate disease that has required treatment (e.g., benign prostatic hypertrophy).
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
543 Patients enrolled
Trial Details
Trial ID
NCT00196807
Start Date
August 1 2004
End Date
November 1 2006
Last Update
January 20 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgetown University Medical Center
Washington D.C., District of Columbia, United States, 20007
2
Howard University Hospital
Washington D.C., District of Columbia, United States, 20060